# 119-s-1040: Drug Competition Enhancement Act

119-s-1040, Drug Competition Enhancement Act, is a 119th Congress bill sponsored by Sen. Cornyn, John [R-TX] (R-TX); status in_committee; PRIA reads it as touching household money (as of 2026-08-11).

- Canonical: https://policyrisk.com/legislation/119-s-1040
- As of: 2026-08-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-1040
- Congress: 119
- Title: Drug Competition Enhancement Act
- Status: in_committee
- Introduced: 2025-03-13
- Sponsor: Sen. Cornyn, John [R-TX] (R-TX)
- Cosponsors: 3
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-08-11

## Summary

**Stops "product hopping" by drugmakers to protect competition from generics and biosimilars.** It would add a new FTC rule that treats certain deliberate formulation or marketing shifts as unfair methods of competition and lets the agency seek injunctions and other remedies.

## Cosponsors (3)

- Sen. Blumenthal, Richard [D-CT] (D-CT), 2025-03-13T00:00:00.000Z
- Sen. Grassley, Chuck [R-IA] (R-IA), 2025-03-13T00:00:00.000Z
- Sen. Durbin, Richard J. [D-IL] (D-IL), 2025-03-13T00:00:00.000Z

## Provisions PRIA read

- New limits on drugmaker product hopping: benefit, high. If enacted, the bill would set limits on brand‑name drug makers shifting patients to a new version to block generics. The FTC could presume unfair conduct in a set window: from notice of a generic or biosimilar filing until the earlier of 180 days after the first generic/biosimilar is sold or 3 yea…
- Stronger FTC tools to police drug switching: benefit, high. If enacted, the FTC would get clearer tools to enforce these rules. It could bring administrative cases or sue in federal court for temporary or permanent orders. The FTC could seek to give up unfair profits and repay buyers within 5 years of the last unfair gain, with disgorgement reduced by any r…

## Related bills

- 119-s-1071: National Defense Authorization Act for Fiscal Year 2026
- 119-s-1748: Kids Online Safety Act
- 119-s-539: PROTECT Our Children Reauthorization Act of 2025
- 119-s-5025: Lindsey O. Graham Sanctioning Russia Act of 2026
- 119-s-1241: Sanctioning Russia Act of 2025
- 119-s-545: Combating Illicit Xylazine Act

## Sources
- [119-s-1040 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/1040)

## Related
- [119-s-1071: National Defense Authorization Act for Fiscal Year 2026](https://policyrisk.com/legislation/119-s-1071)
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-539: PROTECT Our Children Reauthorization Act of 2025](https://policyrisk.com/legislation/119-s-539)
- [119-s-5025: Lindsey O. Graham Sanctioning Russia Act of 2026](https://policyrisk.com/legislation/119-s-5025)
- [119-s-1241: Sanctioning Russia Act of 2025](https://policyrisk.com/legislation/119-s-1241)
- [119-s-545: Combating Illicit Xylazine Act](https://policyrisk.com/legislation/119-s-545)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-1040 (as of 2026-08-11).